ESMO 2024: CC-94676-PCA-001: Clinical Activity of BMS-986365, a Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, in Heavily Pretreated Patients with mCRPC Sep 17 Written By Kristofer Prepelica, PhD Kristofer Prepelica, PhD
ESMO 2024: CC-94676-PCA-001: Clinical Activity of BMS-986365, a Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, in Heavily Pretreated Patients with mCRPC Sep 17 Written By Kristofer Prepelica, PhD Kristofer Prepelica, PhD
